A death prompts withdrawal of promising MS drug
Article Abstract:
Biogen Idec Inc. and Elan Corp. have withdrawn a promising new drug for multiple sclerosis, Tysabri from the market after the death of a patient from a rare nervous system disorder. Both companies have experienced decreased share price.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
Ex-officer at Tyco pleads not guilty to tax charges
Article Abstract:
Tyco International Ltd.'s former chief financial officer, Mark H. Swartz, has entered a not guilty plea to charges of not paying federal income taxes on a 1999 bonus. Swartz received a $12.5 million (11.6 million euros) bonus in 1999.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
CMGI lowers revenue forecast, issues warning
Article Abstract:
CMGI Inc. is expecting to post lower-than-forecasted revenues for the fiscal year ending July 31, 2001. The company also said it will not reach its $1.65 billion (1.77 billion euros) revenue target for the year.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Merging German banks post promising results. Dresdner Bank's net forecast to be solid. Credit Suisse gets ready for expansion in Germany
- Abstracts: Sunoco expands its service offerings. OLC launches two ads and a lottery
- Abstracts: Squabbles over the stimulus. Showing this week: the tax cut. Read his lips
- Abstracts: Currency crossroads. Japan, the yen and the dollar. The only way out?
- Abstracts: BA may defy EU over slots. Starlab plots 'nerds' revenge. Huntington avoids near-closure
